There seems, therefore, to be contrasting evidence for peripheral muscle pathology.
Methods
Twenty three women (aged 20-65 years) were selected for study on the basis of a history typical of acute onset post-viral fatigue syndrome, as defined by Smith.' Their symptoms had been preceded by a history of a "flu"-like illness and had been either relapsing, remitting, or chronic in nature. Their main symptoms were of muscular fatigue associated with discomfort after exercise, lethargy, lack of concentration and short-term memory dysfunction and were associated with many other lesser symptoms.' The duration of symptoms varied from six months to 17 years. These patients had no significant medical or psychiatric history and had been fit and well until the onset of this new disease process. All had had a normal physical examination.
All patients had assays for full blood count, erythrocyte sedimentation rate, white cell differential, and white cell subset assays, a rheumatoid antibody haemagglutination assay, 10 channel SMAC, including estimation of serum glucose and thyroid stimulating hormone. Patients also had viral and antinuclear antibody screens. Similar biochemical data were also obtained from control female patients who attended elective surgery or outpatient clinics for non-specific complaints other than PVFS.
STUDIES ON MUSCLES
Muscle biopsy specimens were taken from the vastus lateralis portion of the quadriceps muscle with a UCH biopsy needle under local anaesthesia, as described by Edwards et al.5 Protein RNA and DNA were measured by the spectrometric and fluorometric techniques, described by Preedy and Peters. '2 Processing of muscle was carried out at 0-40C, unless otherwise stated. Skeletal muscle biopsy specimens were homogenised in 2 ml distilled water, using an ultrasonic tissue homogeniser with a micro-probe (Northern Media Supply Company, Hull, England). Homogenates were then acid precipitated in 0-2 molIl perchloric acid and centrifuged (2000 x g for 20 minutes). The supernatant fluid was discarded and the pellet suspended in 2 ml of 0-2 mol/l perchloric acid, mixed vigorously, and re-centrifuged (2000 x g, for 20 minutes). The supernatant fluid was again discarded and the pellet suspended in 2 ml 0 3 mol/H NaOH for 1 hour. This was acidprecipitated with 0-5 ml, 2 mol/l perchloric acid and centrifuged (2000 x g for 20 minutes). The supernatant fluid was used to determine RNA by the dual wavelength method-at 260 nm and 232 nm, as described by Munro and Table 2 shows data pertaining to body mass index, age, and length of illness. In general, the mean Quetelet's Index did not indicate any overt differences from the control patient range (20) (21) (22) (23) (24) (25) . One patient, however, had a Quetelet's Index of 18-4 (case 10) (table 2) . In all 23 patients light microscopic examination of sections of the muscle biopsy specimens showed that most of the muscle fibres were of normal appearance. Two cases showed occasional split fibres and these were the two cases which had the highest atrophy factors. Two further cases showed a modest amount of centronuclear chains but were normal on histomorphometric analysis. There was no evidence of fibre necrosis, phagocytosis, or of any inflammatory infiltrate in any of the biopsy specimens. Histomorphometric analysis indicated eight patients with atrophy or hypertrophy factors outside the normal range (table 1). These were three patients with hypertrophy of both type I and type II fibres, one patient with hypertrophy of just type I fibres, one patient with hypertrophy of type II fibres and three patients with atrophy of type II fibres (table 1) . It must be emphasised that these were needle biopsy specimens and so, inevitably, are subject to some artefact. A biopsy specimen from case 15, which had the highest hypertrophy factor, appeared particularly disrupted and this may well have produced artefactually large fibres. It is also recognised that some fibres in a needle biopsy specimen may undergo hypercontraction before freezing, and so the samples showing mildly increased hypertrophy factors were probably normal. Table 3 shows that whole-body potassium values in the five patients studied were within the control range. In general, plasma carnosinase and creatine kinase activities were also within the normal ranges, but one patient had a slightly reduced carnosinase activity.
The figure shows that RNA concentrations were reduced in patients with PVFS, by about 15%, though the concomitant decrease in protein:DNA did not reach significance. (20 controls and 20 patients) and determined that, while maximal isometric strength was not affected by the disease process, there was a noticeable inhibition recovery from the peak torque after endurance exercise. 29 These authors concluded that the contrasting data of subjective muscle weakness and objective state of normal muscle function may have been due to altered patient perception of achieved force and exertion. 29 The disease definitions of their patients were, however, different from ours. To a certain extent, these conclusions, are similar to those of Stokes et al who studied patients with effort syndrome.'0 Not all their patients had histories of viral infections before the onset of symptoms. It is appropriate to speculate whether numerous reports in this field do, in fact, examine heterogeneous groups of patients. And there is a fundamental need for a concise and universally accepted medical definition of PVFS. 31 More recently, direct evidence has been obtained for a subcellular metabolic defect in the muscle per se.32 These studies indicate that up to 80% of patients with PVFS have indentifiable mitochondrial abnormalities.'2 Thus deficiencies in energy generation may in some way be related to defects in the turnover of muscle RNA or proteins, which are energy dependent processes. 27 Alternatively, inactivity, or lack of exercise may be precipitating factors for perturbations in protein metabolism in these patients.
